{
    "root": "e9ebf4d2-be60-4908-a43d-3a315f8e9224",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Butorphanol Tartrate",
    "value": "20240101",
    "ingredients": [
        {
            "name": "BUTORPHANOL TARTRATE",
            "code": "2L7I72RUHN"
        },
        {
            "name": "BENZETHONIUM CHLORIDE",
            "code": "PH41D05744"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        }
    ],
    "indications": "butorphanol tartrate nasal spray indicated management pain severe enough require opioid analgesic alternative treatments inadequate . limitations risks addiction , abuse , misuse opioids , occur duration [ ] , reserve butorphanol tartrate nasal spray patients alternative treatment options ( e.g . , non-opioid analgesics opioid combination products ) : \u2022have tolerated expected tolerated , \u2022have provided adequate analgesia expected provide adequate analgesia butorphanol tartrate nasal spray used extended period time unless pain remains severe enough require opioid analgesic alternative treatment options continue inadequate .",
    "contraindications": null,
    "warningsAndPrecautions": "butorphanol tartrate nasal spray , usp supplied child-resistant vial containing 2.5 ml bottle nasal spray solution ( 10 mg/ml ) metered-dose spray pump protective clip dust cover , bottle nasal spray solution , patient instruction leaflet medication guide . average , one bottle deliver 14 15 doses repriming necessary . butorphanol tartrate nasal spray , usp , 10 mg/ml ndc 0054-3090-36 : 2.5 ml bottle .",
    "adverseReactions": "butorphanol tartrate nasal spray contraindicated : \u2022patients significant respiratory depression [ ] . \u2022patients acute severe bronchial asthma unmonitored setting absence resuscitative equipment [ ] . \u2022patients known suspected gastrointestinal obstruction , including paralytic ileus [ ] . \u2022patients hypersensitivity butorphanol tartrate , preservative benzethonium chloride , formulation excipients ( e.g . , anaphylaxis ) [ ] .",
    "indications_original": "Butorphanol Tartrate Nasal Spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. \n                  \n                     Limitations of Use \n                  \n                  Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see WARNINGS], reserve Butorphanol Tartrate Nasal Spray for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): \n                  \n                     \n                        \u2022Have not been tolerated or are not expected to be tolerated, \n                     \n                        \u2022Have not provided adequate analgesia or are not expected to provide adequate analgesia\n                  \n                  Butorphanol Tartrate Nasal Spray should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.",
    "warningsAndPrecautions_original": "Butorphanol Tartrate Nasal Spray, USP is supplied in a child-resistant vial containing a 2.5 mL bottle of nasal spray solution (10 mg/mL) and a metered-dose spray pump with protective clip and dust cover, a bottle of nasal spray solution, and a patient instruction leaflet and medication guide. On average, one bottle will deliver 14 to 15 doses if no repriming is necessary. \n                  \n                     Butorphanol Tartrate Nasal Spray, USP, 10 mg/mL \n                  \n                  NDC 0054-3090-36: 2.5 mL Bottle.",
    "adverseReactions_original": "Butorphanol Tartrate Nasal Spray is contraindicated in: \n                  \n                     \n                        \u2022Patients with significant respiratory depression [see WARNINGS]. \n                     \n                        \u2022Patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see WARNINGS]. \n                     \n                        \u2022Patients with known or suspected gastrointestinal obstruction, including paralytic ileus [see WARNINGS]. \n                     \n                        \u2022Patients with hypersensitivity to butorphanol tartrate, the preservative benzethonium chloride, or any of the formulation excipients (e.g., anaphylaxis) [see WARNINGS]."
}